These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27046072)

  • 1. Pediatric cardiovascular grafts: historical perspective and future directions.
    Heydrick S; Roberts E; Kim J; Emani S; Wong JY
    Curr Opin Biotechnol; 2016 Aug; 40():119-124. PubMed ID: 27046072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
    Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
    J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells for tissue engineering of cardiac valves.
    Jana S; Tranquillo RT; Lerman A
    J Tissue Eng Regen Med; 2016 Oct; 10(10):804-824. PubMed ID: 25712485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Tissue Engineering Heart Valve.
    Shinoka T; Miyachi H
    World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):677-684. PubMed ID: 27834758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tissue engineering for heart valves and vascular grafts].
    Teebken OE; Wilhelmi M; Haverich A
    Chirurg; 2005 May; 76(5):453-66. PubMed ID: 15841408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineered living cardiac and venous valve replacements: current status and future prospects.
    Kehl D; Weber B; Hoerstrup SP
    Cardiovasc Pathol; 2016; 25(4):300-305. PubMed ID: 27167776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing?
    Parvin Nejad S; Blaser MC; Santerre JP; Caldarone CA; Simmons CA
    Adv Drug Deliv Rev; 2016 Jan; 96():161-75. PubMed ID: 26555371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and mechanical evaluation of a Bio-Hybrid scaffold for autologous valve tissue engineering.
    Jahnavi S; Saravanan U; Arthi N; Bhuvaneshwar GS; Kumary TV; Rajan S; Verma RS
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():59-71. PubMed ID: 28183649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute.
    Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE
    Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart valve tissue engineering.
    Vesely I
    Circ Res; 2005 Oct; 97(8):743-55. PubMed ID: 16224074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of: application of synthetic scaffold in tissue engineering heart valves.
    Fallahiarezoudar E; Ahmadipourroudposht M; Idris A; Mohd Yusof N
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():556-65. PubMed ID: 25579957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells.
    Wu KH; Liu YL; Zhou B; Han ZC
    Eur J Cardiothorac Surg; 2006 Nov; 30(5):770-81. PubMed ID: 16963271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue engineering therapy for cardiovascular disease.
    Nugent HM; Edelman ER
    Circ Res; 2003 May; 92(10):1068-78. PubMed ID: 12775655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a Clinically Relevant Tissue Engineered Heart Valve-A Review of Current Approaches.
    Nachlas ALY; Li S; Davis ME
    Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29171921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioengineering challenges for heart valve tissue engineering.
    Sacks MS; Schoen FJ; Mayer JE
    Annu Rev Biomed Eng; 2009; 11():289-313. PubMed ID: 19413511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
    Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
    Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.